Science Futures is Managed by Nola E. Masterson
Nola sits on the Board of Directors of Repros Therapuetics, and Generex Biotechnology. She is on the Board of Directors for Omicia, Inc. a start up in the cardiovascular genomic risk area. The company is seeking 1.5 million in investments to develop a risk index for myocardio infarction for women.